
An independent data monitoring committee has told Roche to halt a study of its experimental lung cancer drug MetMab due …

Roche’s MetMab has shown huge promise in phase II trials in lung cancer – but only in patients with ‘high …
Brenntag and dsm-firmenich expand biopharma vitamin partnership
Migraine annual economic and quality-of-life burden in UK
bit.bio expands human heart cell portfolio through myriamed partnership

